With the rollout of yet another booster shot, questions of safety and efficacy are in the spotlight. On today’s ‘Good Morning CHD,’ Meryl Nass, M.D., breaks down the data that we already have and analyzes the CDC and media responses to adverse events and other concerns. In this episode, Dr. Nass also discusses the process of creating Novavax, manufacturing and costs of ordering doses, the changing definition of a vaccine, databases and reporting systems and more. Viewers, do not miss this!